This article has a delayed release (embargo) and will be available in PMC on April 10, 2025.
Guselkumab for Pityriasis Rubra Pilaris and Dysregulation of IL-23/IL-17 and NFkB Signaling: A Nonrandomized Trial
Rose C. Velasco, Connie Shao, Brett Cutler, Jennifer Strunck, Gail Kent, Pamela B. Cassidy, Keith Choate, Teri M. Greiling
JAMA Dermatol. 2024 Jun; 160(6): 641–645. Published online 2024 Apr 10. doi: 10.1001/jamadermatol.2024.0257
- PMCID:
- PMC11007649
Reason: This article has a delayed release (embargo) and will be available in PMC on April 10, 2025. (An abstract of the
article is available in PubMed, which may also have a link to
the full text of the article at the publishing journal's website.)
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11007649/
Message ID: 591028943
Time: 2024/07/24 02:09:28
If you need further help, please write to the helpdesk. Include the information from the box above in your message.